Ra Capital Management, L.P. I Teos Therapeutics, Inc. Transaction History
Ra Capital Management, L.P.
- $7.17 Billion
- Q3 2024
A detailed history of Ra Capital Management, L.P. transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 3,184,711 shares of ITOS stock, worth $26.5 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
3,184,711
Previous 3,517,259
9.45%
Holding current value
$26.5 Million
Previous $52.2 Million
37.71%
% of portfolio
0.45%
Previous 0.79%
Shares
5 transactions
Others Institutions Holding ITOS
# of Institutions
166Shares Held
36.6MCall Options Held
1.95MPut Options Held
374K-
Black Rock Inc. New York, NY3.73MShares$31 Million0.0% of portfolio
-
Boxer Capital, LLC San Diego, CA2.95MShares$24.5 Million1.6% of portfolio
-
Mpm Asset Management LLC Cambridge, MA2.74MShares$22.8 Million19.24% of portfolio
-
Tang Capital Management LLC San Diego, CA2.41MShares$20 Million2.09% of portfolio
-
Bio Impact Capital LLC Cambridge, MA1.75MShares$14.5 Million2.78% of portfolio
About iTeos Therapeutics, Inc.
- Ticker ITOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,575,300
- Market Cap $296M
- Description
- Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...